logo
搜索
菜单

therapeuti的搜索结果

当前1/12页
排序: 最近更新
4.18: An Overview of Psychoactive Drugs 01:28 min
4.18: An Overview of Psychoactive Drugs
4.3: Altered States of Awareness 01:06 min
4.3: Altered States of Awareness
25.9: Insulin: Dosing Regimen and Adverse Effects 01:16 min
25.9: Insulin: Dosing Regimen and Adverse Effects
17.16: Pharmaceutical Poisoning: Potential Scenarios 01:26 min
17.16: Pharmaceutical Poisoning: Potential Scenarios
17.12: Dose Response Curve: Conventional Versus Nonmonotonic 01:21 min
17.12: Dose Response Curve: Conventional Versus Nonmonotonic
17.10: Drug toxicity: Drug–Drug Interaction 01:30 min
17.10: Drug toxicity: Drug–Drug Interaction
16.16: Ophthalmic Drug Delivery Systems 01:23 min
16.16: Ophthalmic Drug Delivery Systems
16.12: Oral Drug Delivery Systems: Continuous-Release Systems 01:26 min
16.12: Oral Drug Delivery Systems: Continuous-Release Systems
16.9: Modified-Release Drug Delivery Systems: Site-Targeted 01:24 min
16.9: Modified-Release Drug Delivery Systems: Site-Targeted
16.5: Modified-Release Drug Delivery Systems: Drug Release Characteristics 01:22 min
16.5: Modified-Release Drug Delivery Systems: Drug Release Characteristics
16.4: Modified-Release Drug Delivery Systems: Bioavailability 01:30 min
16.4: Modified-Release Drug Delivery Systems: Bioavailability
16.3: Modified-Release Drug Delivery Systems: Influencing Factors 01:20 min
16.3: Modified-Release Drug Delivery Systems: Influencing Factors
16.2: Modified-Release Drug Delivery Systems: Overview 01:19 min
16.2: Modified-Release Drug Delivery Systems: Overview
15.14: Pharmacodynamic Models: Direct Effect Model and Indirect Response Model 01:29 min
15.14: Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
15.5: Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration 01:23 min
15.5: Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect 01:26 min
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
14.9: Pharmacogenomics: Identification of New Drug Targets 01:29 min
14.9: Pharmacogenomics: Identification of New Drug Targets
13.22: Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant 01:25 min
13.22: Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
13.16: Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug 01:14 min
13.16: Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
13.13: Pharmacokinetics in Pediatric Patients: Drug Metabolism 01:24 min
13.13: Pharmacokinetics in Pediatric Patients: Drug Metabolism
返回顶部